squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma#136322ClinicalTrials.gov
• An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.#837232ClinicalTrials.gov
• FALCOn (Facteur AnthropoLogique Cancer Orl)#883295ClinicalTrials.gov
• A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers#373584ClinicalTrials.gov
• Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial#279488ClinicalTrials.gov
• Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the Oesophagus#872960ClinicalTrials.gov
• The use of the mental foramen as a guide for marginal mandibulectomy in oral squamous cell carcinoma patients with tumor-free margins: experience of 15 years#476034HAL (France)
• Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)#857480ClinicalTrials.gov
• A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)#866993ClinicalTrials.gov
• A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe#885964ClinicalTrials.gov
• The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.#873635ClinicalTrials.gov
• Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery#878506ClinicalTrials.gov
• Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma#290974ClinicalTrials.gov
• SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck#887777ClinicalTrials.gov
• Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)#889921ClinicalTrials.gov
• Immunotherapy After Radiotherapy in Elderly ESCC#127597ClinicalTrials.gov
• A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer#146454ClinicalTrials.gov
• Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor#180395ClinicalTrials.gov
• Proteome profiles of esophageal squamous cell carcinoma tie mitochondrial complex I to immunotherapy.#193428NCBI PubMed Central
• a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study#343819ClinicalTrials.gov
• Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）#387168ClinicalTrials.gov
• Circular RNAs in esophageal squamous cell carcinoma: What do we know so far?#399660NCBI PubMed Central
• Immunohistochemical Expression of Novel Therapeutic Targets in Squamous Cell Carcinoma of the Bladder.#402576NCBI PubMed Central
• Social genomics and cancer - untangling nature from nurture in squamous cell carcinoma outcomes.#427732NCBI PubMed Central
• SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma#800920ClinicalTrials.gov
• Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma#810759ClinicalTrials.gov
• Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning#871573ClinicalTrials.gov
• Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus – An ancillary study of the FFCD0904 phase I and II trial#156037HAL (France)
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors#146451ClinicalTrials.gov
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer#880923ClinicalTrials.gov
• Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)#869612ClinicalTrials.gov
• Tislelizumab efficacy and safety compared to other anti–PD-1s: a network meta-analysis of first-line therapies for unresectable, locally advanced or metastatic esophageal squamous cell carcinoma#159320HAL (France)
• Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer#826812ClinicalTrials.gov
• Safety Study of MGD009 in B7-H3-expressing Tumors#894828ClinicalTrials.gov
• Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)#893419ClinicalTrials.gov
• Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors#853622ClinicalTrials.gov
• Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)#870636ClinicalTrials.gov
• Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma.#9065NCBI PubMed Central
• Clinical Significance of Biomarkers in Oropharyngeal Squamous Cell Carcinoma: Recurrence Prediction and Treatment Response.#143143NCBI PubMed Central
• Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma.#165665NCBI PubMed Central
• A monocyte-centered framework for predicting immunochemotherapy efficacy in lung squamous cell carcinoma patients.#193433NCBI PubMed Central
• CXCR4 Inhibition Induces Tumor Necrosis by Selectively Targeting the Proliferating Blood Vessels in Oral Squamous Cell Carcinoma#251456OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Demystifying cutaneous cystic squamous cell carcinoma: a case report and review of the literature.#281010NCBI PubMed Central
• RHEBL1 expression is activated by the Oct4-Sox2 complex in oral squamous cell carcinoma.#308898NCBI PubMed Central
• Serum metabolomics profiling in head and neck squamous cell carcinoma: a multicentre diagnostic study.#380806NCBI PubMed Central
• Hormonal Factors and Risks of Esophageal Squamous Cell Carcinoma and Adenocarcinoma in Postmenopausal Women#384234CiNii
• Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma.#409482NCBI PubMed Central
• Iron homeostasis and macrophage polarization in oral squamous cell carcinoma: mechanisms and therapeutic perspectives.#452895NCBI PubMed Central
• Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC#640558ClinicalTrials.gov
• Predicting Head and Neck Squamous Cell Carcinoma outcomes using long-term Patient-Derived Tumor Organoids#677159HAL (France)